AT
TEVA icon

Arden Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Arden Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,127
Closed -$403K – 362
2017
Q2 		$403K Sell
12,127
-238
-2% -$7.37K 0.06% 259
2017
Q1 		$397K Buy
12,365
+1,966
+19% +$67.1K 0.06% 244
2016
Q4 		$377K Sell
10,399
-1,194
-10% -$47.7K 0.06% 257
2016
Q3 		$533K Sell
11,593
-24,690
-68% -$1.29M 0.08% 218
2016
Q2 		$1.82K Sell
36,283
-4,228
-10% -$225K 0.14% 156
2016
Q1 		$2.17M Sell
40,511
-1,987
-5% -$117K 0.17% 138
2015
Q4 		$2.79M Buy
42,498
+1,668
+4% +$103K 0.24% 102
2015
Q3 		$2.31M Buy
40,830
+11,065
+37% +$717K 0.19% 129
2015
Q2 		$1.76K Sell
29,765
-158
-0.5% -$9.75K 0.26% 97
2015
Q1 		$1.86K Buy
29,923
+13,983
+88% +$813K 0.27% 98
2014
Q4 		$917K Sell
15,940
-405
-2% -$22.6K 0.13% 160
2014
Q3 		$879K Sell
16,345
-648
-4% -$34.3K 0.12% 163
2014
Q2 		$890K Sell
16,993
-772
-4% -$39.5K 0.12% 157
2014
Q1 		$939K Sell
17,765
-628
-3% -$29K 0.12% 155
2013
Q4 		$737K Sell
18,393
-144
-0.8% -$5.67K 0.09% 185
2013
Q3 		$700K Sell
18,537
-181
-1% -$7.06K 0.09% 187
2013
Q2 		$734K Buy
+18,718
New +$729K 0.09% 182

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Arden Trust's TEVA Position: Q3 2017 in Review

Arden Trust sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 12,127 shares — an estimated $403K sold.

Arden Trust first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $2.79M in Q4 2015. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Arden Trust reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Arden Trust sold 12,127 Teva Pharmaceuticals shares in Q3 2017, an estimated $403K.
  • Arden Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Arden Trust's Teva Pharmaceuticals position peaked at $2.79M in Q4 2015.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Arden Trust's 13F filing for Q3 2017, filed 23 Oct 2017.